102 related articles for article (PubMed ID: 7158858)
1. Effect of anesthesia and splenectomy on antibody response to pneumococcal polysaccharide immunization.
Barringer M; Meredith W; Sterchi M; Schiffman G; Meredith J; Beyer F
Am Surg; 1982 Dec; 48(12):628-33. PubMed ID: 7158858
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.
Jones JM; Amsbaugh DF; Prescott B
J Immunol; 1976 Jan; 116(1):52-64. PubMed ID: 1446
[TBL] [Abstract][Full Text] [Related]
3. Improved antibody responses to delayed pneumococcal vaccination in splenectomized rats.
Werner AM; Solis MM; Vogel R; Southerland SS; Ashley AV; Floyd JC; Brown C; Ashley DW
Am Surg; 1999 Sep; 65(9):844-7; discussion 847-8. PubMed ID: 10484087
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.
Jones JM; Amsbaugh DF; Prescott B
J Immunol; 1976 Jan; 116(1):41-51. PubMed ID: 1445
[TBL] [Abstract][Full Text] [Related]
5. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
[TBL] [Abstract][Full Text] [Related]
6. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.
Baker CJ; Kasper DL; Edwards MS; Schiffman G
N Engl J Med; 1980 Jul; 303(4):173-8. PubMed ID: 6155612
[TBL] [Abstract][Full Text] [Related]
7. Enhanced triggering of mucosal immune responses by reducing splenic phagocytic functions.
van den Dobbelsteen GP; Brunekreef K; Kroes H; van Rooijen N; van Rees EP
Eur J Immunol; 1993 Jul; 23(7):1488-93. PubMed ID: 8325324
[TBL] [Abstract][Full Text] [Related]
8. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
9. Effect of splenectomy on the expression of regulatory T cell activity.
Amsbaugh DF; Prescott B; Baker PJ
J Immunol; 1978 Oct; 121(4):1483-5. PubMed ID: 29928
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of splenic regrowth on the reduced antibody responses to pneumococcal polysaccharides in splenectomized patients.
Kiroff GK; Hodgen AN; Drew PA; Jamieson GG
Clin Exp Immunol; 1985 Oct; 62(1):48-56. PubMed ID: 4064376
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively.
Shatz DV; Romero-Steiner S; Elie CM; Holder PF; Carlone GM
J Trauma; 2002 Dec; 53(6):1037-42. PubMed ID: 12478024
[TBL] [Abstract][Full Text] [Related]
13. Maternal-foetal interaction, antibody formation, and metabolic response in mice immunized with pneumococcal polysacharides.
Lee CJ
Immunology; 1980 Sep; 41(1):45-54. PubMed ID: 7429553
[TBL] [Abstract][Full Text] [Related]
14. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
15. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with protein-conjugated and native type 3 capsular polysaccharide in an ethanol-fed rat model of pneumococcal pneumonia.
Henriksen JL; Preheim LC; Gentry MJ
Alcohol Clin Exp Res; 1997 Dec; 21(9):1630-7. PubMed ID: 9438523
[TBL] [Abstract][Full Text] [Related]
17. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus.
McDonald E; Jarrett MP; Schiffman G; Grayzel AI
J Rheumatol; 1984 Jun; 11(3):306-8. PubMed ID: 6737372
[TBL] [Abstract][Full Text] [Related]
18. Relative merits of partial splenectomy, splenic reimplantation, and immunization in preventing postsplenectomy infection.
Cooney DR; Dearth JC; Swanson SE; Dewanjee MK; Telander RL
Surgery; 1979 Oct; 86(4):561-9. PubMed ID: 39355
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
20. Post-immunization pneumococcal antibody titers and IgG subclasses.
Sorensen RU; Hidalgo H; Moore C; Leiva LE
Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
